26
Dihomo-γ-Linolenic Acid | B2751
- SKU:
- 26-B2751-GEN
- Availability:
- Usually shipped in 5 working days
Description
Dihomo-γ-Linolenic Acid (DGLA, 20:3), an elongation product of γ-linolenic acid (18:3), is rapidly metabolized by fatty acid desaturases to produce arachidonic acid (20:4). DGLA is metabolized through the cyclooxygenase pathway to produce 1-series prostaglandins, including PGE1. DGLA also inhibits several key cellular processes associated with atherosclerosis.
Dihomo-γ-Linolenic Acid (DGLA, 20:3), an elongation product of γ-linolenic acid (18:3), is rapidly metabolized by fatty acid desaturases to produce arachidonic acid (20:4). DGLA is metabolized through the cyclooxygenase pathway to produce 1-series prostaglandins, including PGE1. DGLA also inhibits several key cellular processes associated with atherosclerosis.
B2751 | Dihomo-γ-Linolenic Acid DataSheet
Alternate Name/Synonyms: 8Z,11Z,14Z-eicosatrienoic acid,DGLA
Appearance: Liquid
Formulation: A solution in ethanol
CAS Number: 1783-84-2
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₀H₃₄O₂
Molecular Weight: 306.5
Cell-Permeable?: TRUE
Purity: ≥98%
Solubilities:
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An anti-atherogenic agent
MDL Number: MFCD00065721
PubChem CID: 5280581
SMILES: CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O
InChi: InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-
InChi Key: HOBAELRKJCKHQD-QNEBEIHSSA-N
Additional Information
Storage Condition: |
-20ºC |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |